Pre-operative Focused Transthoracic Echocardiography for Prediction of Post-operative Cardiac Complications

NCT04114474 | Completed

• 1 other identifier: transthoracic echocardiograpy
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The extent focused transthoracic echocardiography when done pre-operatively to patients admitted for elective surgery and suspected to be at risk of cardiac disease specially the geriatric population can affect perioperative anesthetic management of these patients.

Conditions

Diastolic Dysfunction

Outcome Measures

Primary Outcomes (1)

• Lt. Ventricular EDV

  Transthoracic echocardiography (TEE) LVEDV

  Change from Baseline pre operative LVEDV to first day postoperative

Interventions

TRANSTHORACIC ECHOCARDIOGRAPY DIAGNOSTIC_TEST

TTE (Vivid I echocardiography machine General Electric Healthcare, Milwaukee, WI, USA) with a 3S-RS (1.5-3.6 MHz) transthoracic probe). was done by professional anesthesiologist following the :Hemodynamic Echocardiography Assessment in Real Time ( HEART) protocol. According to the clinical findings of TTE patients may be either free or have one or more of the following haemodynamic states normal, empty, vasodilated ,left ventricular systolic or diastolic failure, left ventricular systolic and diastolic failure, and right ventricular failure, valve stenosis or regurgitation of at least moderate severity

Eligibility Criteria

• Age: 60 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Eligibility for participating in the study was assessed before assignment by the attending physician in the anesthesia clinic . Patients above 60 years of age ASAI and ASA II were included in the study unless history of cardiac disease, history of previous postoperative cardiac complications and symptoms or signs of cardiac diseases were found as theses patients were excluded from the study.

You may qualify if:

• Patients above 60 years of age ASAI and ASA II were included

You may not qualify if:

• history of cardiac disease, history of previous postoperative cardiac complications and symptoms or signs of cardiac diseases.

Sponsors & Collaborators

• South Egypt Cancer Institute: lead

Study Sites (1)

South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt

Asyut, 0020, Egypt

Location

Study Officials

• ALAA A EALZOHRY, MD

  Lecturer of Anesthesia, ICU and Pain Relief, South Egypt Cancer Institute.

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer of Anesthesia, ICU and Pain Relief, South Egypt Cancer Institute, Assiut University.

Study Record Dates

• First Submitted: September 27, 2019
• First Posted: October 3, 2019
• Study Start: October 1, 2017
• Primary Completion: December 1, 2018
• Study Completion: December 30, 2018
• Last Updated: October 18, 2019

Record last verified: 2019-10

Locations

EG (1)